Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
MyMD Pharmaceuticals, Inc. (MYMD)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
24 Aug 2023
Rivard Paul
Chief Legal Officer, Officer
MyMD Pharmaceuticals, Inc.
(MYMD)
400,000
+60%
150,000
$1.11
$166,500.00
BUY
17 Aug 2023
Rivard Paul
Chief Legal Officer, Officer
MyMD Pharmaceuticals, Inc.
(MYMD)
250,000
+11%
25,000
$1.12
$28,080.00
BUY
8 Dec 2022
Rivard Paul
EVP of Operations, GC, Officer
MyMD Pharmaceuticals, Inc.
(MYMD)
225,000
+4%
10,000
$1.53
$15,300.00
BUY
24 Nov 2021
Silverman Joshua
Director
MyMD Pharmaceuticals, Inc.
(MYMD)
88,775
+20%
15,000
$6.89
$103,357.66
BUY
23 Nov 2021
Rivard Paul
EVP of Operations, GC, Officer
MyMD Pharmaceuticals, Inc.
(MYMD)
215,000
+7%
15,000
$6.03
$90,450.00
SELL
28 Feb 2020
Hudson Bay Capital Management LP
10% Owner
Akers Biosciences, Inc.
(AKER)
240,305
-0%
319
$5.62
$1,792.78
SELL
25 Feb 2020
Hudson Bay Capital Management LP
10% Owner
Akers Biosciences, Inc.
(AKER)
240,943
-5%
14,150
$5.62
$79,576.00
BUY
9 Dec 2019
Hudson Bay Capital Management LP
10% Owner
Akers Biosciences, Inc.
(AKER)
269,243
+52%
92,289
$6.02
$555,550.40
BUY
24 May 2016
Gormally John J
Chief Executive Officer, Officer
Akers Biosciences Inc
(AKER)
69
+10%
6.51
$855.07
$5,566.86
BUY
5 Jan 2016
AKERS RAYMOND FRANCIS JR
Executive Chairman, Secretary, Director, Officer
Akers Biosciences Inc
(AKER)
72,100
+0%
5.469
$514.56
$2,814.00
Home